A significant advance in cancer research is occurring with the use of VHH fragments to re-engage mutated p53. This essential malignant protector protein is frequently lost in several kinds of malignancies, causing https://bookmarkchamp.com/story21890140/nanobodies-reactivate-tumor-suppressor-p53-new-new-approach-for-malignant-therapy